Russia claims promising signs in early trials of antiviral drug favipiravir

over 5 years in nationalpost

MOSCOW — A candidate drug for treating the new coronavirus, favipiravir, has produced promising results in early clinical trials in Russia, according to the Russian Direct Investment Fund, which provided 150 million roubles ($2 million) in funding for the project. RDIF head Kirill Dmitriev said 60% of the 40 coronavirus patients taking tablets of favipiravir, […]

Mentioned in this news
Share it on